|
Volumn 22, Issue 3, 1996, Pages 365-367
|
First clinical experience with ADEPT
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBODIES;
DISEASES;
DRUG PRODUCTS;
ENZYMES;
ANTIBODY DIRECTED ENZYME PRODRUG THERAPY;
IMMUNOSUPPRESSIVE AGENTS;
MICE;
MURINE MONOCLONAL ANTIBODY;
TUMOUR;
DRUG THERAPY;
ANTIBODY;
ANTIBODY CONJUGATE;
ANTINEOPLASTIC AGENT;
CARCINOEMBRYONIC ANTIGEN;
CYCLOSPORIN A;
DIMETHYL SULFOXIDE;
ENZYME;
FLUOROURACIL;
FOLINIC ACID;
PRODRUG;
ANTIBODY DIRECTED ENZYME PRODRUG THERAPY;
ANTIBODY RESPONSE;
BONE MARROW TOXICITY;
CLINICAL TRIAL;
COLON ADENOCARCINOMA;
HUMAN;
METASTASIS;
NAUSEA;
NEUTROPHILIA;
NONHUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
THROMBOCYTOPENIA;
VOMITING;
|
EID: 0030589525
PISSN: 0169409X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0169-409X(96)00443-7 Document Type: Review |
Times cited : (39)
|
References (7)
|